PFBC Stock Analysis: Preferred Bank | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 1.228m USD | 12M Return: 13.2% | US7403674044 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 9.90M
EPS Trend: 24.5%
Qual. Beats: 0
Rev. Trend: 7.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Preferred Bank (NASDAQ: PFBC) is a Los Angeles-based regional bank founded in 1991 that provides a full suite of banking products and services. Its deposit offerings include checking, savings, money market accounts, certificates of deposit, and individual retirement accounts, while its lending portfolio spans real estate mortgage and construction loans, commercial loans, and Small Business Administration (SBA) loans.
The bank primarily serves small and mid-sized businesses, entrepreneurs, real estate developers, professionals, and high net worth individuals. Beyond traditional deposit and lending products, it offers trade finance services such as letters of credit and documentary collections, along with cash management and digital banking through internet, mobile, and tablet platforms.
As a regional bank, Preferred Bank operates under a relationship-based business model focused on specific geographic and customer segments rather than competing nationally, a common approach among community banking institutions. The SBA loans it originates are partially guaranteed by the U.S. Small Business Administration, which reduces lender credit risk while supporting small business access to financing.
- CRE loans grow as commercial real estate demand strengthens in California
- Net interest margin expands with Fed rate holds supporting asset yields
- Trade finance revenue rises on increased cross-border activity with Asian markets
| Net Income: 132.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.15 > 1.0 |
| NWC/Revenue: 143.2% < 20% (prev -1.08k%; Δ 1.22k% < -1%) |
| CFO/TA 0.03 > 3% & CFO 206.4m > Net Income 132.5m |
| Net Debt (-267.8m) to EBITDA (191.8m): -1.40 < 3 |
| Current Ratio: 467.4 > 1.5 & < 3 |
| Outstanding Shares: last quarter (12.1m) vs 12m ago -4.40% < -2% |
| Gross Margin: 55.80% > 18% (prev 55.15%; Δ 0.64% > 0.5%) |
| Asset Turnover: 6.56% > 50% (prev 6.70%; Δ -0.14% > 0%) |
| Interest Coverage Ratio: 0.89 > 6 (EBIT TTM 190.1m / Interest Expense TTM 212.6m) |
| A: 0.09 (Total Current Assets 719.4m - Total Current Liabilities 1.54m) / Total Assets 7.82b |
| B: 0.11 (Retained Earnings 849.8m / Total Assets 7.82b) |
| C: 0.02 (EBIT TTM 190.1m / Avg Total Assets 7.64b) |
| D: 0.11 (Book Value of Equity 792.4m / Total Liabilities 7.02b) |
| Altman-Z'' = 1.24 = BB |
| DSRI: 0.92 (Receivables 38.3m/41.6m, Revenue 501.4m/500.5m) |
| GMI: 0.99 (GM 55.15% / 55.80%) |
| AQI: 1.02 (AQ_t 0.90 / AQ_t-1 0.88) |
| SGI: 1.00 (Revenue 501.4m / 500.5m) |
| TATA: -0.01 (NI 132.5m - CFO 206.4m) / TA 7.82b) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of November 20, 2026, the stock is trading at USD 99.49 with a total of 62,194 shares traded. Over the past week, the price has changed by -3.85%, over one month by -3.96%, over three months by -2.80% and over the past year by +13.23%.
Current recommended Stop Loss: 95.10 (which is 4.4% or 1.8 ATR below the current price).
Preferred Bank has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold PFBC.
- StrongBuy: 1
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 117.5 | 18.1% |
P/E Trailing = 9.5809
P/E Forward = 8.3195
P/S = 4.3248
P/B = 1.5524
P/EG = 0.9441
Revenue TTM = 501.4m USD
EBIT TTM = 190.1m USD
EBITDA TTM = 191.8m USD
Long Term Debt = 348.9m USD (from longTermDebt, last quarter)
Short Term Debt = 1.54m USD (from shortTermDebt, last quarter)
Debt = 413.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 32.2m
Net Debt = -267.8m USD (calculated: Debt 413.3m - CCE 681.0m)
Enterprise Value = 959.9m USD (1.23b + Debt 413.3m - CCE 681.0m)
Interest Coverage Ratio = 0.89 (Ebit TTM 190.1m / Interest Expense TTM 212.6m)
EV/FCF = 7.13x (Enterprise Value 959.9m / FCF TTM 134.7m)
FCF Yield = 14.03% (FCF TTM 134.7m / Enterprise Value 959.9m)
FCF Margin = 26.86% (FCF TTM 134.7m / Revenue TTM 501.4m)
Net Margin = 26.42% (Net Income TTM 132.5m / Revenue TTM 501.4m)
Gross Margin = 55.80% ((Revenue TTM 501.4m - Cost of Revenue TTM 221.6m) / Revenue TTM)
Gross Margin QoQ = 55.44% (prev 57.33%)
Tobins Q-Ratio = 0.12 (Enterprise Value 959.9m / Total Assets 7.82b)
Interest Expense / Debt = 51.46% (Interest Expense 212.6m / Debt 413.3m)
Taxrate = 30.32% (57.6m / 190.1m)
NOPAT = 132.5m (EBIT 190.1m * (1 - 30.32%))
Current Ratio = 39.27 (Total Current Assets 719.4m / Total Current Liabilities 18.3m)
Debt / Equity = 0.52 (Debt 413.3m / totalStockholderEquity, last quarter 792.4m)
Debt / EBITDA = -1.40 (Net Debt -267.8m / EBITDA 191.8m)
Debt / FCF = -1.99 (Net Debt -267.8m / FCF TTM 134.7m)
Total Stockholder Equity = 786.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.73% (Net Income 132.5m / Total Assets 7.82b)
RoE = 16.84% (Net Income TTM 132.5m / Total Stockholder Equity 786.4m)
RoCE = 16.74% (EBIT 190.1m / Capital Employed (Equity 786.4m + L.T.Debt 348.9m))
RoIC = 1.70% (NOPAT 132.5m / Invested Capital 7.79b)
WACC = 5.15% (E(1.23b)/V(1.64b) * Re(6.88%) + (debt cost/tax rate unavailable))
Discount Rate = 6.88% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.10 | Cagr: -4.98%
[DCF] Terminal Value 74.89% ; FCFF base≈136.9m ; Y1≈132.9m ; Y5≈131.6m
[DCF] Fair Price = 196.6 (EV 2.06b - Net Debt -267.8m = Equity 2.33b / Shares 11.9m; r=8.35% [WACC [floored]]; 5y FCF grow -3.96% → 2.50% )
EPS Correlation: 24.52 | EPS CAGR: 1.46% | SUE: 0.31 | # QB: 0
Revenue Correlation: 7.59 | Revenue CAGR: 0.16% | SUE: 0.66 | # QB: 0
EPS current Quarter (2027-03-31): EPS=2.74 | Chg30d=+3.95% | Revisions=+12% | Analysts=6
EPS current Year (2026-12-31): EPS=10.83 | Chg30d=+0.81% | Revisions=+67% | GrowthEPS=+4.0% | GrowthRev=-0.3%
EPS next Year (2027-12-31): EPS=11.38 | Chg30d=+3.20% | Revisions=+62% | GrowthEPS=+5.1% | GrowthRev=+7.7%
[Analyst] Revisions Ratio: +63% (up=14, down=2)